Impact Therapeutics Nets HK$120 Million From Full Exercise of IPO Overallotment Option
MT Newswires Live
Jun 08
Impact Therapeutics (HKG:7630) said the overallotment option of its Hong Kong initial public offering was fully exercised on Friday, according to a same-day Hong Kong bourse filing.
The Chinese biopharmaceutical company expects to raise about HK$119.5 million in additional net proceeds.
The exercise involved the issue of 6.3 million additional H-shares at HK$20.10 each, representing about 15% of the total offer shares initially available under the global offering.
Dealings in the overallotment shares are expected to begin on June 10, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.